Long term follow-up of a phase II trial of multimodal therapy given in a "sandwich" method for stage III, IV, and recurrent endometrial cancer.

Michelle GlasgowRachel Isaksson VogelJennifer BurgartPeter ArgentaKathryn DusenberyMelissa A Geller

Published in: Gynecologic oncology research and practice (2016)

After additional follow-up, OS and PFS estimates remain high and in-field recurrences low following "sandwich" therapy. The "sandwich" method remains efficacious for women with stage III-IV or recurrent endometrial cancer.

Keyphrases

endometrial cancer
randomized controlled trial
clinical trial
cell therapy
study protocol